Deep Tech Startups

Milvus Advanced is a deeptech company that designs and manufactures high-performance nanomaterials and nanoalloys from abundant raw materials as replacements for scarce materials such as platinum-group metals. Its materials are engineered for integration into existing industrial systems.

5 investors

Mirai builds on-device AI models, an inference runtime, and infrastructure designed to run low-latency, continuous AI assistants directly on devices such as Apple Silicon hardware. The company develops the full local AI stack so that a single assistant can resolve tasks across multiple services on-device rather than through cloud-based chatbots.

5 investors

Mission Bio develops single-cell biology tools and platforms for researchers and clinicians to enable precision medicine discovery and cancer treatment. The company serves the biomedical research and clinical diagnostics market.

5 investors

Momenta develops autonomous driving software for automakers, offering L2/L2+ assisted driving and L3 autonomous driving systems for mass-produced vehicles. It partners with global OEMs to deploy driver assistance features such as automatic steering, lane changes, and parking.

5 investors

Xsens develops motion capture systems and inertial sensor modules based on sensor fusion technology for applications in humanoid robotics, entertainment, health, sports, and industrial automation. The company transforms physical movement into accurate digital data for professional use across these industries.

5 investors

Mueon builds data center-scale infrastructure designed for next-generation AI workloads.

5 investors

Multifactor provides zero-trust authentication, authorization, and auditing services. The company serves developers and end users requiring secure identity verification and access control solutions.

5 investors

Multiply Labs builds robotic systems that automate biologics manufacturing for pharmaceutical companies. The platform orchestrates existing laboratory instruments in a closed, sterile environment to increase throughput by up to 100x while reducing costs and contamination risk.

5 investors

Nelumbo develops PFAS-free surface coatings for anti-ice and water repellency, including IceNein for heat exchangers in refrigeration and HVAC systems to reduce ice formation and improve energy efficiency, and Mineral for durable water-repellent textiles. It serves refrigeration and HVAC asset owners and operators as well as textile manufacturers.

5 investors

Neusignal Therapeutics develops novel drugs for central nervous system disorders, including dementia and psychiatric conditions, with research focused on calcium signaling in neurons and target discovery for brain diseases. The company serves the pharmaceutical/biotech market and is based in Tokyo, Japan.

5 investors

NextSilicon develops software-defined hardware architecture for high-performance computing in scientific research, enabling developers to accelerate existing code without rewrites or vendor lock-in. The company targets researchers in fields including cancer therapy, physics, and cosmology.

5 investors

Nomic offers an end-to-end protein profiling service built on its nELISA technology, quantifying up to 1000 informative proteins with absolute quantification for research studies. It targets researchers doing proteomics work, aiming for high-throughput, low-cost profiling in the biotech and life sciences market.

5 investors

NOX operates AI-powered metal manufacturing facilities that provide cut-to-spec metal products to American manufacturers with quote and delivery times measured in milliseconds rather than days. The company uses machine learning for inventory optimization, job scheduling, and bin-packing to reduce lead times and scrap in metal supply.

5 investors

Nurix Therapeutics develops targeted protein degradation medicines, including degrader-antibody conjugates (DACs), designed to eliminate disease-causing proteins using the cell's natural degradation machinery. It uses a DEL-AI drug discovery engine to advance a multi-modal clinical pipeline targeting diseases in oncology, immunology, and neurology.

5 investors

NUVIEW is building a constellation of commercial satellites to collect LiDAR data and annually map the Earth's entire land surface, producing high-resolution 3D elevation, terrain, and surface models. Its data and analytics serve applications in forestry, climate, agriculture, infrastructure, disaster management, telecommunications, defense, and government mapping programs.

5 investors

Omen provides continuous fluid analysis sensors that monitor the health of critical hardware in real time, detecting equipment failures before they occur across data centers and industrial machinery.

5 investors

oneNav develops small, low-power L5-band GNSS positioning technology for military, government, commercial, and consumer applications such as drones, trackers, aviation, and consumer devices. The company designs GNSS receiver hardware and software focused on accuracy and reliability using modern satellite signals.

5 investors

ONI develops the Nanoimager, an automated super-resolution imaging system. The company serves researchers and laboratories in life sciences and microscopy applications.

5 investors

OpenStar develops compact fusion energy technology using a levitated dipole approach and high-temperature superconducting systems, working toward commercial fusion. The company originated from the Robinson Research Institute in New Zealand.

5 investors

Orbital Ops develops propulsion systems and related aerospace hardware for airborne vehicles. The company draws on deep expertise in turbomachinery and propulsion integration.

5 investors

Orca AI applies computer vision and deep learning to maritime shipping, providing situational awareness and automation tools to help commercial vessels navigate more safely and operate more efficiently. The company builds technology aimed at moving the shipping industry toward smart and autonomous ships.

5 investors

Orionis Biosciences discovers and engineers molecules that connect proteins on or within cells to reprogram disease-driving processes or activate immune responses. It develops therapeutics for cancer, autoimmune diseases, and neurodegenerative disorders through collaborations with industry and academic institutions.

5 investors

Orqa manufactures the MRM2-10, an NDAA-compliant, EU-made dual-use drone platform built from carbon fibre that carries payloads up to 3.5 kg for tactical and commercial operators. The system features an electronic-warfare-resilient IRONghost sub-GHz control link, a modular airframe, and integration with flight firmwares and C2 ecosystems like ATAK and MAVLINK.

5 investors

Orum is a global biopharmaceutical company developing cancer therapies that combine protein degraders with antibodies. It focuses on Degrader Antibody Conjugate (DAC) technology to research and develop new therapeutics.

5 investors